长基因间非蛋白编码RNA-重编程调节因子在高级别卵巢浆液性癌中的表达与功能
研究收集2014年6月至2016年2月34例高级别卵巢浆液性癌组织和19例正常输卵管组织,检测Linc-ROR表达并分析其与FIGO分期及淋巴结转移的关系,同时在SKOV3细胞中过表达或敲低Linc-ROR以评估增殖、迁移和侵袭能力。结果显示癌组织Linc-ROR表达显著高于正常输卵管组织,且随FIGO分期进展而升高、与淋巴结转移相关;敲低Linc-ROR抑制细胞增殖、迁移和侵袭,过表达则增强这些能力。
要点
- 高级别卵巢浆液性癌组织Linc-ROR mRNA表达显著高于正常输卵管组织(4.31±0.38 vs 1.03±0.21,P<0.01)。
- Linc-ROR表达随FIGO分期进展而升高(F=95.702,P<0.01),且与淋巴结转移相关(t=7.397,P<0.01)。
- 敲低Linc-ROR可抑制SKOV3细胞增殖、迁移和侵袭,过表达则增强这些能力。
核心结论
- 高表达的Linc-ROR可增强高级别卵巢浆液性癌细胞的增殖、迁移和侵袭能力,可能是该癌发生发展、侵袭转移的重要分子之一。
研究设计与样本
- 收集2014年6月至2016年2月34例高级别卵巢浆液性癌组织和19例正常输卵管组织,采用实时逆转录PCR检测Linc-ROR mRNA表达,并分析其与FIGO分期及淋巴结转移的关系。
- 构建Linc-ROR小干扰RNA和pIRES2-EGFP-Linc-ROR质粒,分别转染SKOV3细胞,用CCK-8、划痕实验和Transwell侵袭实验评估细胞增殖、迁移和侵袭能力。
主要发现
- 高级别卵巢浆液性癌组织Linc-ROR mRNA表达显著高于正常输卵管组织(4.31±0.38 vs 1.03±0.21;t=25.842,P<0.01)。
- 随FIGO分期进展Linc-ROR表达升高(F=95.702,P<0.01),且与淋巴结转移相关(t=7.397,P<0.01)。
- Linc-ROR-i组Linc-ROR表达显著低于Linc-ROR-NC-i组(0.30±0.11 vs 1.02±0.10;t=15.269,P<0.01);Linc-ROR-p组显著高于Linc-ROR-NC-p组(8.90±0.45 vs 1.03±0.17;t=21.934,P<0.01)。
- CCK-8实验显示培养第3、4、5、6天时Linc-ROR-i组A值显著低于Linc-ROR-NC-i组(P<0.05),Linc-ROR-p组A值显著高于Linc-ROR-NC-p组(P<0.05)。
- 划痕实验培养48小时后Linc-ROR-i组迁移率显著低于Linc-ROR-NC-i组[(52±4)% vs(67±5)%;t=5.720,P<0.01],Linc-ROR-p组显著高于Linc-ROR-NC-p组[(84±4)% vs(66±4)%;t=7.330,P<0.01];Transwell侵袭实验培养48小时后Linc-ROR-i组侵袭细胞数低于Linc-ROR-NC-i组(74±3 vs 104±3;t=15.810,P<0.01),Linc-ROR-p组高于Linc-ROR-NC-p组(217±4 vs 108±5;t=38.060,P<0.01)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the expression of long intergenic non-protein coding RNA-regulator of reprogramming (Linc-ROR) in high-grade ovarian serous cancer, and explore the relationship between Linc-ROR expression and biological function of high-grade ovarian serous cancer. Methods: A total of 34 high-grade ovarian serous cancer tissue samples and 19 normal fallopian tube tissue samples were collected between June 2014 and February 2016. Real-time reverse transcription (RT)-PCR was used to detect the Linc-ROR mRNA expression in different samples. The relationship between Linc-ROR expression level and ovarian cancer International Federation of Gynecology and Obstetrics (FIGO) stage, lymph node metastasis was analyzed. Constructed Linc-ROR small interference RNA (siRNA) and pIRES2-EGFP-Linc-ROR plasmid, then Linc-ROR siRNA and pIRES2-EGFP-Linc-ROR plasmid were respectively transfected into SKOV3 cells. Cell proliferation, migration and invasion ability were assessed by cell counting kit-8 (CCK-8), wound healing assay and transwell invasion assay. Results: (1) The expression level of Linc-ROR mRNA was significantly higher in high-grade ovarian serous cancer than normal fallopian tube tissues (4.31± 0.38 vs 1.03 ± 0.21; t=25.842, P<0.01). With the progression of FIGO stages, the expression of Linc-ROR was increased (F=95.702, P<0.01), and it was associated with lymph node metastasis (t=7.397, P<0.01). (2) The results of RT-PCR showed that the expression level of linc-ROR in Linc-ROR-i group was significantly lower than that in Linc-ROR-NC-i group (0.30 ± 0.11 vs 1.02 ± 0.10; t=15.269, P<0.01). The expression level in Linc-ROR-p group was significantly higher than that in Linc-ROR-NC-p group (8.90± 0.45 vs 1.03±0.17; t=21.934, P<0.01). The CCK-8 assay showed that when the cells were cultured for 3, 4, 5 and 6 days, the A value in Linc-ROR-i group was significantly lower than that in Linc-ROR-NC-i group (P< 0.05). And the A value in Linc-ROR-p group was significantly higher than that in Linc-ROR-NC-p group (P< 0.05). Wound healing assay showed that, after 48 hours incubation, migration rate of cells in Linc-ROR-i group was significantly less than that in the Linc-ROR-NC-i group [(52±4)% vs (67±5)%; t=5.720, P< 0.01]. The migration of cells in Linc-ROR-p group was significantly greater than that in the Linc-ROR-NC-p group [(84±4)% vs (66±4)%; t=7.330, P <0.01]. Cell transwell invasion assay showed that, after 48 hours of incubation, the number of invasive cells in Linc-ROR-i group was lower than that in Linc-ROR-NC-i group (74 ± 3 vs 104 ± 3; t=15.810, P<0.01). And the number of invasive cells in Linc-ROR-p group was higher than that in Linc-ROR-NC-p group (217 ± 4 vs 108 ± 5; t=38.060, P<0.01). Conclusion: Highly expressed Linc-ROR could enhance the proliferation, migration and invasion ability of high-grade ovarian serous cancer cells, which may be one of the important molecules in the occurrence and development, invasion and metastasis of high-grade ovarian serous cancer.
引用
- Jiang HH, Lou YH, Wang XY, et al. [Expression and function of long intergenic non-protein coding RNA-regulator of reprogramming in high-grade ovarian serous cancer]. Zhonghua Fu Chan Ke Za Zhi. 2016. PMID: 28057128. doi:10.3760/cma.j.issn.0529-567X.2016.12.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。